Breaking News

Canon Medical Offers New Liver Reporting Tool for Ultrasound

To help easily and accurately determine cut off values, Canon Medical Systems USA, Inc.’s premium AplioTM i-series ultrasound platform is now available with software to display the calculated measurement averages from multiple samples of the liver, customizable based on the “Rule of Four.”

Rithem Life Sciences Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions.

1st Patients Enrolled in STEM Trial for `Treatment of Chronic Subdural Hematoma

This marks the first patients enrolled in a prospective, randomized, international trial of a liquid embolic agent for the treatment of chronic subdural hematoma (cSDH), a common disease affecting primarily older adults.

Genius AI Detection Receives FDA Clearance – New Deep Learning-based Software Designed to Help Radiologists Detect Subtle Potential Cancers in Breast Tomosynthesis Images

This new technology, represents a pivotal milestone in the early detection of breast cancer, as studies showed Genius AI Detection software aids in the identification and early detection of breast cancer when used with the Genius® 3D Mammography™ exam.

Passio Pump Drainage System Granted 510(k) for Additional Indication for Home Use

The Passio Pump Drainage System consists of the Passio Catheter, a Handheld Control Unit (pump) and a Disposable Collection Kit, which includes a redressing kit, for drainage of recurrent and symptomatic pleural effusion.

ARUP Laboratories Now Offers COVID-19 Saliva Testing – Available with Preapproval to ARUP Clients Nationwide

September 11, 2020

ARUP Laboratories reports their molecular diagnostic test is available with preapproval to ARUP clients nationwide. COVID-19 testing on saliva specimens offers significant benefits to both individuals and healthcare providers. Spitting into a funnel attached to the top of a collection tube is less invasive than a deep nasal swab performed by a healthcare provider. Providers benefit because they face less risk of exposure by infected individuals who cough or sneeze after enduring a nasopharyngeal swab.

ARUP Laboratories will perform the test only on saliva specimens collected using an ARUP collection kit with a healthcare provider present. ARUP validated the test using its kit on high-throughput instruments, and cannot perform it on other saliva specimens without jeopardizing quick turnaround times, said Adam Barker, Ph.D., director of ARUP’s new COVID-19 Rapid Response Lab.

“Offering accurate, high-quality COVID-19 testing and delivering results quickly to as many patients as possible is part of our commitment to excellent patient care,” Barker said.

ARUP moved quickly to offer COVID-19 saliva testing after researchers at ARUP and University of Utah Health found self-collected saliva and nasopharyngeal swabs collected by healthcare providers are equally effective for detecting SARS-CoV-2, the virus that causes COVID-19. Their study, published in the Journal of Clinical Microbiology, is one of the largest specimen-type comparisons to date.

U of U Health began offering ARUP’s COVID-19 saliva test on Sept. 1, and is using this specimen source to test for COVID-19 infection in most clinical settings. ARUP is a nonprofit enterprise of the U of U and its Department of Pathology. In addition to performing all testing for U of U Health, ARUP has thousands of hospital and health-system clients nationwide.

“We’re pleased to be one of the first labs to offer a COVID-19 saliva test that makes high-quality testing easier for patients and for providers,” said ARUP CEO Sherrie L. Perkins, MD, PhD. “ARUP remains committed to research, development and performance of tests that improve diagnosis of COVID-19 and all other diseases.”

In addition to COVID-19 molecular diagnostic testing, ARUP offers two IgG antibody tests to detect previous exposure to SARS-CoV-2. It also offers numerous tests that help guide treatment of the virus.

Latest Posts

Face Shield Market Is Estimated to Grow Globally from USD 3.0 billion in 2020 to USD 4.1 Bil by 2025, at a CAGR of 65%

Face shield market size is estimated to grow globally from USD 3.0 billion in 2020 to USD 4.1 billion by 2025, at a CAGR of 6.5%.

Acquisition of Moldworx, LLC by Sunningdale Tech Ltd Completed Effective November 6, 2020

On November 6, 2020, the acquisition of Moldworx by global precision plastics manufacturer, Sunningdale Tech Ltd (Singapore) via its wholly-owned subsidiary, Sunningdale Tech Inc, a Michigan Corporation, was completed.

1st PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer Receives FDA Approval

"Ga 68 PSMA-11 is an important tool that can aid health care providers in assessing prostate cancer," said Alex Gorovets, M.D., acting deputy director of the Office of Specialty Medicine in FDA's Center for Drug Evaluation and Research. "With this first approval of a PSMA-targeted PET imaging drug for men with prostate cancer, providers now have a new imaging approach to detect whether or not the cancer has spread to other parts of the body."

Don't Miss

New England Biolabs Announces Further Expansion of Their RNA Depletion Product Portfolio with the Launch of the NEBNext Custom RNA Depletion Design Tool and NEBNext RNA Depletion Core Reagent...

Together, these enable a fully customizable workflow for improved removal of specific RNAs, including abundant RNAs such as ribosomal RNA

INTERCEPT Blood System for Cryoprecipitation Receives FDA Approval States Cerus Corporation

The system is used to produce Pathogen Reduced Cryoprecipitated Fibrinogen Complex for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. 

Genetron Health Provides Update on HCCscreen™ for Liver Cancer Early Screening in China

Establishes joint venture with Wuxi municipal government; Expects the commercialization and revenues of HCCscreen to accelerate in China.

Research Paper Showing ProtoKinetix AAGP® Enhanced Stem Cell Derived Retina Precursor Cells Restoration of Vision

ProtoKinetix notes the research paper has been submitted to a prestigious journal specializing in tissue regeneration for peer review and editing.

OrganaBio to Expand Its cGMP Cell and Gene Therapy Manufacturing Facility: 19,000 Sq. Ft. Slated to Commence Operations In Q3 2021

OrganBio, a Miami-based cGMP facility, will include process development space, ISO 7 cleanrooms, state-of-the-art scientific equipment, analytics and QC laboratories, and a suite of support services to enable OrganaBio and its partners to rapidly and economically self-manufacture clinical materials.